Aterectomía orbital a 3 vasos guiada por corregistro en enfermedad coronaria multivaso calcificada

  1. Asad Shabbir 1
  2. David Chipayo Gonzales 1
  3. Adrián Jerónimo Baza 1
  4. Alejandro Travieso González 1
  5. Nieves Gonzalo 1
  6. Javier Escaned 1
  1. 1 Unidad de Cardiología Intervencionista, Hospital Clínico San Carlos IDISSC, Universidad Complutense de Madrid, Madrid, España
Revista:
REC: Interventional Cardiology

ISSN: 2604-7276,  2604-7306

Año de publicación: 2023

Volumen: 5

Número: 4

Páginas: 307-310

Tipo: Artículo

DOI: 10.24875/RECIC.M23000400 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: REC: Interventional Cardiology

Referencias bibliográficas

  • 1. Riley RF, Henry TD, Mahmud E, et al. SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease. Catheter Cardiovasc Interv. 2020;96:346-362.
  • 2. Khan AA, Murtaza G, Khalid MF, et al. Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis:A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2021;98:884-892.
  • 3. Escaned J, Collet C, Ryan N, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease:1-year results of the SYNTAX II study. Eur Heart J. 2017;38:3124-3134.
  • 4. Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC Cardiovasc Interv. 2014;7:510-518.
  • 5. Lee M, Genereux P, Shlofmitz R, et al. Orbital atherectomy for treating de novo, severely calcified coronary lesions:3-year results of the pivotal ORBIT II trial. Cardiovasc Revasc Med. 2017;18:261-264.
Fuente de los datos: Dialnet